☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Urovant
Urovant Entered into an Exclusive License Agreement with Pierre Fabre Médicament to Commercialize Vibegron for Overactive Bladder
July 6, 2022
PharmaShots Weekly Snapshots (Jan 18 - 22, 2021)
January 22, 2021
Insights+: The US FDA New Drug Approvals in December 2020
January 21, 2021
PharmaShots Weekly Snapshot (Nov 23 - 27, 2020)
November 27, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
